-
Mashup Score: 8Daniel Herranz, PharmD, PhD @HerranzLab @RutgersCancer - 2 year(s) ago
Daniel Herranz, PharmD, Ph.D., Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School & Resident Member at
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Podcast-Daniel Herranz, PharmD, PhD @HerranzLab @Rutger - 2 year(s) ago
Daniel Herranz, PharmD, Ph.D., Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School & Resident Member at
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Sirt1 A Novel Therapeutic Target in T-ALL Daniel Herranz, PharmD, PhD @HerranzLab @RutgersCancer #ASH21 #OlgaLanchoPhD #Sirt1 #ALL #Research https://t.co/a0lHV33My8 https://t.co/WrRDUAMGl9